As outside report urges increased planning and culture changes, FDA OTS Director Keller says recruitment will stop ‘order taking’ and move to ‘forecasting the hiring needs of each of the centers.’
With a streamlined hiring process pilot showing improvements, the US Food and Drug Administration also is looking to change the tone of its recruitment efforts.
FDA officials no longer want to discuss the number of vacancies, which is a static number at a particular point...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
